Should I buy or sell InnovAge stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares. View INNV analyst ratings or view top-rated stocks .

What is InnovAge's stock price target for 2024?

2 Wall Street analysts have issued twelve-month price targets for InnovAge's stock. Their INNV share price targets range from $7.00 to $9.00. On average, they anticipate the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts .

How have INNV shares performed in 2023?

InnovAge's stock was trading at $7.18 at the beginning of the year. Since then, INNV stock has decreased by 17.0% and is now trading at $5.96. View the best growth stocks for 2023 here .

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.04. The company earned $182.49 million during the quarter, compared to analyst estimates of $176.81 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%.

What other stocks do shareholders of InnovAge own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU) , Antares Pharma (ATRS) , Federal National Mortgage Association (FNMA) , Medicines (MDCO) , Frontier Communications (FTR) , FedEx (FDX) , Republic First Bancorp (FRBK) , Aytu BioPharma (AYTU) , NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI) .

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

InnovAge Stock Price, News & Analysis (OTCMKTS:INNV)

$5.96

+0.06 (+1.02%)

(As of 12/4/2023 ET)

Compare

Today's Range: $5.60
▼
$6.00
50-Day Range: $5.18
▼
$6.54
52-Week Range: $5.04
▼
$8.15

Volume: 66,837 shs
Average Volume: 36,104 shs
Market Capitalization: $809.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.00

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines Insider Trades Ownership SEC Filings

InnovAge MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 34.2% Upside
$8.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.09
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.25) to ($0.05) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.70 out of 5 stars

3.0

Analyst's Opinion

Consensus Rating
InnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.00, InnovAge has a forecasted upside of 34.2% from its current price of $5.96.
Amount of Analyst Coverage
InnovAge has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for INNV.

0.0

Dividend Strength

Dividend Yield
InnovAge does not currently pay a dividend.
Dividend Growth
InnovAge does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INNV.

3.4

News and Social Media Coverage

News Sentiment
InnovAge has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for InnovAge this week, compared to 0 articles on an average week.
MarketBeat Follows
1 people have added InnovAge to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InnovAge insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.41% of the stock of InnovAge is held by insiders.
Percentage Held by Institutions
Only 12.17% of the stock of InnovAge is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for InnovAge are expected to grow in the coming year, from ($0.25) to ($0.05) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of InnovAge is -19.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of InnovAge is -19.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
InnovAge has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About InnovAge Stock (OTCMKTS:INNV)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INNV Stock News Headlines

December 1, 2023 | finance.yahoo.com

InnovAge Announces Acquisition of ConcertoCare’s PACE Programs

December 1, 2023 | americanbankingnews.com

InnovAge (OTCMKTS:INNV) vs. Ramsay Health Care (OTCMKTS:RMSYF) Head to Head Survey

December 5, 2023 | Edge On The Street (Ad)

The Battery Metal Nobody Told You About

According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."

November 30, 2023 | americanbankingnews.com

InnovAge (OTCMKTS:INNV) Share Price Passes Above Fifty Day Moving Average of $5.77

November 7, 2023 | finance.yahoo.com

InnovAge Announces Financial Results For The Fiscal First Quarter Ended September 30, 2023

September 13, 2023 | finance.yahoo.com

InnovAge Holding Corp. (NASDAQ:INNV) Q4 2023 Earnings Call Transcript

September 11, 2023 | benzinga.com

Earnings Preview: InnovAge Holding

September 10, 2023 | msn.com

Dow futures trade flat, fresh inflation data in focus

December 5, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

September 10, 2023 | msn.com

INNVInnovAge Holding Corp.

August 29, 2023 | finance.yahoo.com

InnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023

August 16, 2023 | benzinga.com

Performance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On Wednesday

August 14, 2023 | finance.yahoo.com

InnovAge Strengthens Board with Appointment of New Independent Director

July 6, 2023 | bizjournals.com

InnovAge taps former health care investment banker for newly vacated CFO role

July 5, 2023 | finance.yahoo.com

InnovAge Names Ben Adams as New Chief Financial Officer

July 5, 2023 | finance.yahoo.com

Estimating The Intrinsic Value Of InnovAge Holding Corp. (NASDAQ:INNV)

June 27, 2023 | msn.com

InnovAge Holding: EBITDA In Focus With No More Sanctions

June 16, 2023 | msn.com

InnovAge Holding: Gross Productivity, Multiples Speak Volumes

June 8, 2023 | finance.yahoo.com

InnovAge Holding (NASDAQ:INNV) soars 17% this week, taking one-year gains to 48%

June 5, 2023 | finance.yahoo.com

InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference

May 11, 2023 | msn.com

Recap: InnovAge Holding Q3 Earnings

May 11, 2023 | finance.yahoo.com

InnovAge Holding Third Quarter 2023 Earnings: EPS Misses Expectations

May 10, 2023 | bizjournals.com

InnovAge points to small but steady signs of growth after release from final sanctions

May 10, 2023 | finance.yahoo.com

InnovAge Holding Corp. (INNV) Reports Q3 Loss, Lags Revenue Estimates

May 9, 2023 | finance.yahoo.com

InnovAge Announces Financial Results For The Fiscal Third Quarter Ended March 31, 2023

May 8, 2023 | markets.businessinsider.com

What Wall Street expects from InnovAge's earnings

May 1, 2023 | finance.yahoo.com

Final Sanction Removed at InnovAge Sacramento PACE Center Enabling New Participant Enrollment

See More Headlines

Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 12/05/2023
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Care Facilities
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:INNV
Previous Symbol: NASDAQ:INNV
CUSIP: N/A
CIK: 1411879
Web: www.innovuspharma.com
Phone: 844-803-8745
Fax: N/A
Employees: 2,100
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $8.00
High Stock Price Target: $9.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +34.2%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.29)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,520,000.00
Net Margins: -6.17%
Pretax Margin: -7.63%
Return on Equity: -13.04%
Return on Assets: -7.48%

Debt

Debt-to-Equity Ratio: 0.25
Current Ratio: 1.57
Quick Ratio: 1.57

Sales & Book Value

Annual Sales: $699.35 million
Price / Sales: 1.16
Cash Flow: $0.09 per share
Price / Cash Flow: 65.41
Book Value: $2.50 per share
Price / Book: 2.38

Miscellaneous

Outstanding Shares: 135,885,000
Free Float: 135,311,000
Market Cap: $809.87 million
Optionable: Not Optionable
Beta: 0.19

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Patrick Blair (Age 52)
President & CEO
Comp: $1.51M
Ms. Nicole D'Amato (Age 44)
Chief Legal Officer & Corporate Secretary
Comp: $678.76k
Dr. Richard A. Feifer FACP (Age 56)
M.D., M.P.H., Chief Medical Officer
Comp: $588.97k
Mr. Edward Moore Kennedy Jr. (Age 62)
J.D., Independent Director
Comp: $100k
Hon. Marilyn Barbour Tavenner M.H.A. (Age 62)
R.N., Independent Director
Comp: $120k
Mr. Benjamin Crowninshield Adams (Age 59)
Chief Financial Officer
Ms. Christine Bent (Age 53)
Chief Operations Officer
Ms. Cara Babachicos
Chief Information Officer
Mr. Ryan Kubota
Director of Investor Relations
Ms. Olivia Patton
Chief Compliance Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

INNV Stock Analysis - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings or view top-rated stocks.
What is InnovAge's stock price target for 2024?: 2 Wall Street analysts have issued twelve-month price targets for InnovAge's stock. Their INNV share price targets range from $7.00 to $9.00. On average, they anticipate the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price.
View analysts price targets for INNV or view top-rated stocks among Wall Street analysts.
How have INNV shares performed in 2023?: InnovAge's stock was trading at $7.18 at the beginning of the year. Since then, INNV stock has decreased by 17.0% and is now trading at $5.96.
View the best growth stocks for 2023 here.
How were InnovAge's earnings last quarter?: InnovAge Holding Corp. (OTCMKTS:INNV) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.04. The company earned $182.49 million during the quarter, compared to analyst estimates of $176.81 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%.

What other stocks do shareholders of InnovAge own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Federal National Mortgage Association (FNMA), Medicines (MDCO), Frontier Communications (FTR), FedEx (FDX), Republic First Bancorp (FRBK), Aytu BioPharma (AYTU), NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI).
How do I buy shares of InnovAge?: Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:INNV) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

InnovAge Stock Price, News & Analysis (OTCMKTS:INNV)

InnovAge MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About InnovAge Stock (OTCMKTS:INNV)

INNV Stock Price History

INNV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

INNV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™